UNDERWRITING AGREEMENT RayzeBio, Inc. [●] Shares of Common StockUnderwriting Agreement • September 11th, 2023 • RayzeBio, Inc. • Pharmaceutical preparations • New York
RayzeBio, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of [●] shares of the Company (collectively, the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
RAYZEBIO, INC. INDEMNITY AGREEMENTIndemnity Agreement • September 11th, 2023 • RayzeBio, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of , 2023, is made by and between RAYZEBIO, INC., a Delaware corporation (the “Company”), and (“Indemnitee”).
